$15.11▴ 0.47%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$3.09MTTM operating cash
Pre-profit
It generates operating cash even though it has no reported profit yet.
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
+8.1%year over year
Decelerating
Growth is positive but slowing.
Leverage
Not enough data yet
Term-debt data is not available for this company.
More coming: dilution / share-count creep.
Fair value
Fairly valued
Trading right around our fair-value range
Value-trap risk
A cash-flow (DCF) estimate cross-checked against peer multiples.
✦ The read
AngioDynamics, Inc. is pre-profit. It generates operating cash even though it has no reported profit yet. Growth is positive but slowing.
Key numbers
Valuation
EPS (TTM)$-0.87
TTM (trailing 12 months, through fiscal Q4 FY2026)
Profitability
Net margin-11.5%
TTM (trailing 12 months, through fiscal Q4 FY2026)
Size
Revenue (TTM)$320.17M
TTM (trailing 12 months, through fiscal Q4 FY2026)
Signals and key numbers are from the fiscal Q4 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.